Determine the role of the SAA-Macrophage Axis on respiratory pathogen clearance in smoke exposure related lung disease.

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Direct or second hand exposure to tobacco smoke significantly increases your risk of acquiring a chest infection. Infants and elderly smokers are particularly susceptible. This will continue to be a major global problem as household smoke exposure remains high in developing countries and disadvantaged indigenous communities. We will investigate how smoke alters important immune cells that normally clear lung infections, which may lead to completely new ways of treating chest infections.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $617,810.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Respiratory Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

chronic obstructive pulmonary disease (COPD) | innate immunity | macrophages | respiratory diseases | smoking-related diseases